These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22136096)

  • 21. Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?
    Barzman DH; McConville BJ; Masterson B; McElroy S; Sethuraman G; Moore K; Kahwaty AM; Nelson D
    J Affect Disord; 2005 Nov; 88(3):279-85. PubMed ID: 16169087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
    Aman M; Buitelaar J; Smedt GD; Wapenaar R; Binder C
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials.
    LeBlanc JC; Binder CE; Armenteros JL; Aman MG; Wang JS; Hew H; Kusumakar V
    Int Clin Psychopharmacol; 2005 Sep; 20(5):275-83. PubMed ID: 16096518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study.
    Biederman J; Mick E; Faraone SV; Wozniak J; Spencer T; Pandina G
    Clin Ther; 2006 May; 28(5):794-800. PubMed ID: 16861101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-grouped differences in bipolar mania.
    Safer DJ; Magno Zito J; Safer AM
    Compr Psychiatry; 2012 Nov; 53(8):1110-7. PubMed ID: 22682679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
    Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
    J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
    Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
    Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
    Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
    J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome with divalproex in children and adolescents with bipolar disorder.
    Henry CA; Zamvil LS; Lam C; Rosenquist KJ; Ghaemi SN
    J Child Adolesc Psychopharmacol; 2003; 13(4):523-9. PubMed ID: 14977465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bipolar disorders as co-morbidity in childhood and adolescence--underdiagnosed or overinterpreted? Therapy of a 14-year-old boy with hyperkinetic conduct disorder and hypomania].
    Rothermel B; Poustka L; Banaschewski T; Becker K
    Z Kinder Jugendpsychiatr Psychother; 2010 Mar; 38(2):123-9; quiz 130. PubMed ID: 20200829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
    Donovan SJ; Stewart JW; Nunes EV; Quitkin FM; Parides M; Daniel W; Susser E; Klein DF
    Am J Psychiatry; 2000 May; 157(5):818-20. PubMed ID: 10784478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divalproex for the treatment of aggression associated with adolescent mania.
    DelBello MP; Adler C; Strakowski SM
    J Child Adolesc Psychopharmacol; 2004; 14(2):325-8. PubMed ID: 15319029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.